Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/1998
06/30/1998US5773478 Composition comprising methylphenidate and another drug
06/30/1998US5773477 Combination therapy to treat osteoporosis - polyphosphonates and estrogen agonists
06/30/1998US5773476 Methods and compositions for inhibiting cell proliferative disorders
06/30/1998US5773473 Creatine supplement
06/30/1998US5773472 Method and means for prevention of cataract
06/30/1998US5773471 Treatment of optic nerve disorder with prostanoic acid compounds
06/30/1998US5773470 Treating rheumatic diseases, autoimmune diseases and rejection reactions due to organ transplanting
06/30/1998US5773469 Diaryl antimicrobial agents
06/30/1998US5773467 Inhibitors of phosphodiesterases and tumor necrosis factor
06/30/1998US5773466 Pharmaceutical product comprising sympathomimetic drug having therapeutic properties on the human sensibility and autocinesis in general
06/30/1998US5773465 Tartronic acids, their acetalic ethers and o-esters
06/30/1998US5773463 Decalcification of brain disorders
06/30/1998US5773462 Biflavanoids and derivatives thereof as antiviral agents
06/30/1998US5773461 Antitumor agents
06/30/1998US5773457 Compositions
06/30/1998US5773455 Inhibitors of prenyl transferases
06/30/1998US5773453 Administering nonsteroidal antiinflammatory agent prior to administering niacin
06/30/1998US5773452 Alzheimer's disease; cognition activators
06/30/1998US5773451 Bactericides for helicobacter bacteria
06/30/1998US5773450 Fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles
06/30/1998US5773448 Nervous system disorders
06/30/1998US5773447 4-amino-2-ureidopyrimidine-5-carboxamide formed by amidation
06/30/1998US5773446 Diamino pyrimidines
06/30/1998US5773444 Quinazolines as inhibitors of endothelin converting enzyme
06/30/1998US5773443 Triazole antifungal agents
06/30/1998US5773441 Prodrugs; animal husbandry
06/30/1998US5773440 Antiinflammatory agent
06/30/1998US5773439 Nervous system disorders
06/30/1998US5773438 Synthetic matrix metalloprotease inhibitors and use thereof
06/30/1998US5773436 Use of serotonin antagonists for treating fibromyalgia
06/30/1998US5773434 Facilitation of AMPA receptor-mediated synaptic transmission in brain as a treatment for schizophrenia
06/30/1998US5773433 Substituted tetracyclic oxazepine and thiazepine derivatives
06/30/1998US5773432 Using certain 17-difluoromethylene-estratrienes in the treatment and prevention of premature occlusive arterial disease
06/30/1998US5773431 Administration of a 27-hydroxycholesterol or prodrug thereof as an anti-cancer agent
06/30/1998US5773430 Reduces tissue destruction during inflammation resulting from the activity of human leukocyte elastase
06/30/1998US5773429 Drug combination for treating calcium loss
06/30/1998US5773426 Proteoglucan and antidiabetic drug thereof
06/30/1998US5773425 Antineoplastic uses of aloe products
06/30/1998US5773424 Parasiticide
06/30/1998US5773421 Antifungal fusacandins
06/30/1998US5773419 Method of treating cancer with tannic acid
06/30/1998US5773417 Blood substitutes
06/30/1998US5773284 Reacting glycine amide with benzaldehyde
06/30/1998US5773263 Production aflastatin A from streptomyces sp., a pharmaceutical composition and methods of use
06/30/1998US5773231 Treatment for atherosclerosis and other cardiovascular and inflammatory diseases
06/30/1998US5773209 Prevention of formation of oxidized polyunsaturated fatty acid, suppression of gene expression through redox sensitive pathways
06/30/1998US5773052 Betaine as a substitute for supplementary methionine in animal diets
06/30/1998US5773031 Acetaminophen sustained-release formulation
06/30/1998US5773027 Liposomes encapsulating antiviral drugs
06/30/1998US5773026 Aqueous formulations of water-insoluble therapeutic agent comprising carotenoids and/or tocopherols
06/30/1998US5773023 Enhanced skin penetration system for improving topical delivery of drugs
06/30/1998US5773019 Inner core containing an effective amount of a low solubility agent covered by a non-bioerodible polymer coating layer that is permeable to the low solubility agent
06/30/1998US5773015 Method for controlling skin oils and grease
06/30/1998US5773005 Purified flavonoid and diterpene 5α-reductase inhibitors from thuja orientalis for androgen-related diseases
06/30/1998US5773001 Conjugates of methyltrithio antitumor agents and intermediates for their synthesis
06/30/1998US5773000 Therapeutic treatment of clostridium difficile associated diseases
06/30/1998US5772997 Monoclonal antibodies directed to the HER2 receptor
06/30/1998US5772990 Composition for slowing down the loss of hair based on pyrimidine N-oxides triaminosubstituted or their sulfoconjugated
06/30/1998US5772987 Photoprotective/cosmetic compositions comprising TiO2 nanopigments and acylamino acids
06/30/1998US5772629 Tfpi = tissue factor pathway inhibitor
06/30/1998CA2239926A1 N-linked sulfonamides of heterocyclic thioesters
06/30/1998CA2227506A1 New ellipticine derivatives, their preparation process and the pharmaceutical compositions containing them
06/30/1998CA2094084C Aqueous gel vehicles for retinoids
06/30/1998CA2085344C Injectable pharmaceutical composition
06/30/1998CA2008815C Tetrahydrobenzimidazole derivatives
06/27/1998WO1998029612A1 Tree planting concrete product
06/27/1998CA2225906A1 3-deoxyglucosone production inhibitor
06/27/1998CA2223740A1 Use of sophorolipids as an agent to stimulate the metabolism of dermal fibroblasts
06/25/1998WO1998027426A1 Channel mediating substrates
06/25/1998WO1998027206A2 POLYPEPTIDES OF THE 'BASIC-HELIX-LOOP-HELIX' bHLH FAMILY, CORRESPONDING NUCLEIC ACID SEQUENCES
06/25/1998WO1998027108A2 New amide compounds and their use as nitric oxide synthase inhibitors
06/25/1998WO1998027106A1 Aminosterol ester compounds
06/25/1998WO1998027098A1 SUBSTITUTED NITROGEN CONTAINING HETEROCYCLES AS INHIBITORS OF p38 PROTEIN KINASE
06/25/1998WO1998027097A1 Tricyclic quinoxaline derivatives as neuroprotective agents
06/25/1998WO1998027094A1 Ethylidene derivatives of tricyclic carbapenems
06/25/1998WO1998027086A1 Novel heterocyclic substituted pyrrolidine amide derivatives
06/25/1998WO1998027085A1 Novel carboxy substituted cyclic carboxamide derivatives
06/25/1998WO1998027081A1 Sulphonamide derivatives, process for their preparation, and their use as medicaments
06/25/1998WO1998027078A1 New 4-(1-piperazinyl)benzoic acid derivatives, process for preparing them and their therapeutic applications
06/25/1998WO1998027073A1 Asymmetric synthesis of benzoxazinones
06/25/1998WO1998027070A1 Heterocyclic carboxylic acid derivatives, the production and use thereof as endothelin receptor antagonists
06/25/1998WO1998027069A1 Piperazine compounds as inhibitors of mmp or tnf
06/25/1998WO1998027066A1 Isoquinolinamine and phthalazinamine derivatives which interact with crf receptors
06/25/1998WO1998027065A1 Modulators of proteins with phosphotyrosine recognition units
06/25/1998WO1998027058A2 N-piperazin-1-ylphenyl-benzamide derivatives
06/25/1998WO1998027055A1 Aminoindan derivatives
06/25/1998WO1998027052A1 Process for the preparation of nmda antagonists
06/25/1998WO1998026791A1 The use of a cimicifuga racemosa extract
06/25/1998WO1998026788A1 Medical composition and use thereof for the manufacture of a topical barrier formulation, a uv-radiation absorbing formulation, or an antiviral, antifungal, or antiinflammatory formulation
06/25/1998WO1998026787A1 Prebiotics and probiotics
06/25/1998WO1998026786A1 Caged membrane-permeant inositol phosphates
06/25/1998WO1998026785A1 Use of mifepristone for the treatment of psychoses and addictive behaviours
06/25/1998WO1998026784A1 A method for preventing or controlling cataract
06/25/1998WO1998026783A1 Uses of anti-glucocorticoid compounds for the treatment of psychoses or addictive behaviours
06/25/1998WO1998026782A1 Use of 2-(2-morpholinophenyl) guanidine derivatives for the treatment of diabetes complications
06/25/1998WO1998026781A1 Method of treating or inhibiting neutropenia
06/25/1998WO1998026780A2 Flat medicament preparation for the application and release of buprenorphine or a pharmacologically comparable substance in the buccal cavity, and method of producing the same
06/25/1998WO1998026779A1 The use of 7-(2-oxa-5,8-diazabicyclo[4.3.0]non-8-yl)-quinolone carboxylic acid and naphthyridon carboxylic acid derivatives for the treatment of helicobacter pylori infections and associated gastroduodenal diseases
06/25/1998WO1998026778A1 Remedies/preventives for abnormal motions accompanying disorders in extrapyramidal system
06/25/1998WO1998026777A1 Ophtalmic viscoelastic compositions
1 ... 6637 6638 6639 6640 6641 6642 6643 6644 6645 6646 6647 6648 6649 6650 6651 6652 6653 6654 6655 6656 6657 ... 7860